Wyszukaj badanie kliniczne
6 Wyniki
Badanie kliniczne z otwartÄ… rekrutacjÄ…
= 
; Badanie kliniczne w toku
= 
; Ufundowane przez członka IRDiRC = 
; MISSING CONTENT = 
Krajowe badania kliniczne
HOLANDIA
Noord-Holland
AMSTERDAM
Orale Miglustat Toediening aan Volwassen Patiënten met Stabiele Ziekte van Gaucher Type 1
Amsterdam UMC, locatie AMC
Afdeling Erfelijke Stofwisselingsziekten
HOLANDIA
Noord-Holland
AMSTERDAM
ENCORE : A phase 3, randomized, multi-center, multi-national, open-label, active comparator study to evaluate the efficacy and safety of Genz-112638 in patients with Gaucher disease type 1 who have reached therapeutic goals with enzyme replacement therapy - NL
Amsterdam UMC, locatie AMC
Afdeling Erfelijke Stofwisselingsziekten
HOLANDIA
Noord-Holland
AMSTERDAM
ENGAGE - A phase 3, randomized, double-blind, placebo-controlled, multi-center study confirming the efficacy and safety of Genz-112638 in patients with Gaucher disease type 1 - NL
Amsterdam UMC, locatie AMC
Afdeling Erfelijke Stofwisselingsziekten
HOLANDIA
Noord-Holland
AMSTERDAM
EDGE: A Phase 3, Randomized, Multi-Center, Multi-National, Double-Blind Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once Daily Versus Twice Daily Dosing of Genz-112638 in Patients With Gaucher Disease Type 1 Who Have Demonstrated Clinical Stability on a Twice Daily Dose of Genz-112638 - NL
Amsterdam UMC, locatie AMC
Afdeling Erfelijke Stofwisselingsziekten
HOLANDIA
Noord-Holland
AMSTERDAM
MODIFY: A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Determine the EffIcacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease (Phase III) - NL
Amsterdam UMC, locatie AMC
Afdeling Erfelijke Stofwisselingsziekten
HOLANDIA
Noord-Holland
AMSTERDAM